Project Details
| Status | Active |
|---|---|
| Effective start/end date | 04/29/26 → 01/17/27 |
Funding
- IQVIA Incorporated: $1.00
BioNTech SE: A Phase I/II, multi-site, open-label, two-part trial to evaluate the efficacy, safety, and pharmacokinetics of BNT323 in combination with BNT327 in participants with advanced breast cancer
- Almanzar, Lawrence (CoI)
- Andrzejczyk, Anna (CoI)
- Baer, Lea (CoI)
- Cohen, Jules (CoI)
- Stopeck, Alison (CoI)
Project: Research